By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Capstone Therapeutics 

1275 West Washington

Tempe  Arizona  85281  U.S.A.
Phone: 602-286-5520 Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
Capstone Therapeutics (CAPS) Announces Initiation Of Dosing For AEM-28 Phase 1b/2a Human Clinical Trial In Refractory Hypercholesterolemic Subjects 6/12/2014 7:23:53 AM
Capstone Therapeutics Announces Initiation Of Dosing For AEM-28 Phase 1b/2a Human Clinical Trial In Refractory Hypercholesterolemic Subjects 6/11/2014 8:35:14 AM
Capstone Therapeutics (CAPS) Announces Operating Update Conference Cal 5/19/2014 9:51:14 AM
Capstone Therapeutics (CAPS) Announces Initiation Of Dosing For AEM-28 Phase 1 Human Clinical Trial In LDL/Non-HDL Cholesterol Reduction 4/8/2014 7:34:37 AM
Capstone Therapeutics (CAPS) Announces Operating Update Conference Call, Planned Initiation Of AEM-28 Phase 1 Study And Fiscal Year 2013 Financial Results 3/27/2014 9:04:54 AM
Capstone Therapeutics (CAPS) Announces Operating Update Conference Call 3/25/2014 9:11:29 AM
Capstone Therapeutics (CAPS) Announces A Lipimetix Development, LLC Presentation At The American Heart Association Scientific Sessions: Pre-Clinical Data Demonstrating Significant Post Treatment Benefit Of AEM-28 On Established Atherosclerotic Lesions 11/19/2013 9:18:34 AM
Capstone Therapeutics (CAPS) Will Provide an Operating Update and Announces Second Quarter 2013 Financial Results 8/14/2013 8:08:05 AM
Capstone Therapeutics (CAPS) to Hold Quarterly Operating Update Conference Call 8/8/2013 9:57:16 AM
Capstone Therapeutics (CAPS) Will Provide an Operating Update and Announces First Quarter 2013 Financial Results 5/15/2013 9:01:10 AM
1234567
//-->